169 related articles for article (PubMed ID: 26496938)
1. TrkA is amplified in malignant melanoma patients and induces an anti-proliferative response in cell lines.
Pasini L; Re A; Tebaldi T; Ricci G; Boi S; Adami V; Barbareschi M; Quattrone A
BMC Cancer; 2015 Oct; 15():777. PubMed ID: 26496938
[TBL] [Abstract][Full Text] [Related]
2. NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number.
Woo CW; Lucarelli E; Thiele CJ
Oncogene; 2004 Feb; 23(8):1522-30. PubMed ID: 14691455
[TBL] [Abstract][Full Text] [Related]
3. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
4. Ectopic nerve growth factor prevents proliferation in glioma cells by senescence induction.
Meco D; Di Francesco AM; Melotti L; Ruggiero A; Riccardi R
J Cell Physiol; 2019 May; 234(5):6820-6830. PubMed ID: 30417351
[TBL] [Abstract][Full Text] [Related]
5. Acidic substitution of the activation loop tyrosines in TrkA supports nerve growth factor-dependent, but not nerve growth factor-independent, differentiation and cell cycle arrest in the human neuroblastoma cell line, SY5Y.
Gryz EA; Meakin SO
Oncogene; 2003 Nov; 22(54):8774-85. PubMed ID: 14647472
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
[TBL] [Abstract][Full Text] [Related]
7. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
Zhang Y; Dang C; Ma Q; Shimahara Y
Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
[TBL] [Abstract][Full Text] [Related]
8. NGF-withdrawal induces apoptosis in pancreatic beta cells in vitro.
Pierucci D; Cicconi S; Bonini P; Ferrelli F; Pastore D; Matteucci C; Marselli L; Marchetti P; Ris F; Halban P; Oberholzer J; Federici M; Cozzolino F; Lauro R; Borboni P; Marlier LN
Diabetologia; 2001 Oct; 44(10):1281-95. PubMed ID: 11692177
[TBL] [Abstract][Full Text] [Related]
9. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
[TBL] [Abstract][Full Text] [Related]
10. NGF increases VEGF expression and promotes cell proliferation via ERK1/2 and AKT signaling in Müller cells.
Wang J; He C; Zhou T; Huang Z; Zhou L; Liu X
Mol Vis; 2016; 22():254-63. PubMed ID: 27081296
[TBL] [Abstract][Full Text] [Related]
11. Nerve growth factor-induced protein kinase C stimulation contributes to TrkA-dependent inhibition of p75 neurotrophin receptor sphingolipid signaling.
Plo I; Bono F; Bezombes C; Alam A; Bruno A; Laurent G
J Neurosci Res; 2004 Aug; 77(4):465-74. PubMed ID: 15264216
[TBL] [Abstract][Full Text] [Related]
12. Detection of NGF-receptors TrkA and p75NTR in human tumor cell lines and effect of NGF on the growth characteristic of the UT-7/EPO cell line.
Westphal G; van den Berg-Stein S; Braun K; Knoch TA; Dümmerling M; Langowski J; Debus J; Friedrich E
J Exp Clin Cancer Res; 2002 Jun; 21(2):255-67. PubMed ID: 12148587
[TBL] [Abstract][Full Text] [Related]
13. Different effects of TrkA expression in neuroblastoma cell lines with or without MYCN amplification.
Eggert A; Ho R; Ikegaki N; Liu XG; Brodeur GM
Med Pediatr Oncol; 2000 Dec; 35(6):623-7. PubMed ID: 11107132
[TBL] [Abstract][Full Text] [Related]
14. Phosphoinositide-3-kinase and mitogen activated protein kinase signaling pathways mediate acute NGF sensitization of TRPV1.
Zhu W; Oxford GS
Mol Cell Neurosci; 2007 Apr; 34(4):689-700. PubMed ID: 17324588
[TBL] [Abstract][Full Text] [Related]
15. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma.
Davidson B; Reich R; Lazarovici P; Ann Flørenes V; Nielsen S; Nesland JM
Breast Cancer Res Treat; 2004 Jan; 83(2):119-28. PubMed ID: 14997042
[TBL] [Abstract][Full Text] [Related]
16. Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer.
Ma J; Jiang Y; Jiang Y; Sun Y; Zhao X
J Gastroenterol Hepatol; 2008 Dec; 23(12):1852-9. PubMed ID: 19120874
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
Eggert A; Ikegaki N; Liu XG; Brodeur GM
Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551
[TBL] [Abstract][Full Text] [Related]
18. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma.
Davidson B; Reich R; Lazarovici P; Nesland JM; Skrede M; Risberg B; Tropé CG; Flørenes VA
Clin Cancer Res; 2003 Jun; 9(6):2248-59. PubMed ID: 12796393
[TBL] [Abstract][Full Text] [Related]
19. Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells.
Edsjö A; Hallberg B; Fagerström S; Larsson C; Axelson H; Påhlman S
Cell Growth Differ; 2001 Jan; 12(1):39-50. PubMed ID: 11205744
[TBL] [Abstract][Full Text] [Related]
20. Type I interferons up-regulate the expression and signalling of p75 NTR/TrkA receptor complex in differentiated human SH-SY5Y neuroblastoma cells.
Dedoni S; Olianas MC; Ingianni A; Onali P
Neuropharmacology; 2014 Apr; 79():321-34. PubMed ID: 24333329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]